XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements Of Condition - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Assets      
Cash and due from banks $ 308,639 $ 286,167 $ 448,755
Federal funds sold and securities purchased under resale agreements 56 309 59
Interest-bearing deposits with banks 3,825,823 2,164,560 2,260,806
Available-for-sale securities, at fair value 2,946,459 3,106,214 2,270,059
Held-to-maturity securities, at amortized cost, net of allowance for credit losses of $63 at September 30, 2020 ($575.9 million, $1.1 billion and $1.1 billion fair value at September 30, 2020, December 31, 2019 and September 30, 2019 respectively) 560,267 1,134,400 1,095,802
Trading account securities 1,720 1,068 3,204
Equity securities with readily determinable fair value 54,398 50,840 46,086
Federal Home Loan Bank and Federal Reserve Bank stock 135,568 100,739 92,714
Brokerage customer receivables 16,818 16,573 14,943
Mortgage loans held-for-sale, at fair value 959,671 377,313 464,727
Allowance for loan losses (325,959) (156,828) (161,763)
Loans, net of unearned income 32,135,555 26,800,290 25,710,171
Premises and equipment, net 774,288 754,328 721,856
Lease investments, net 230,373 231,192 228,647
Financing Receivable, after Allowance for Credit Loss 31,809,596 26,643,462 25,548,408
Accrued interest receivable and other assets 1,424,728 1,061,141 1,087,864
Goodwill 644,644 645,220 584,315
Other intangible assets 38,670 47,057 43,657
Total assets 43,731,718 36,620,583 34,911,902
Deposits:      
Non-interest bearing 10,409,747 7,216,758 7,067,960
Interest bearing 25,434,675 22,890,380 21,642,419
Total deposits 35,844,422 30,107,138 28,710,379
Federal Home Loan Bank advances 1,228,422 674,870 574,847
Other borrowings 507,395 418,174 410,488
Subordinated notes 436,385 436,095 435,979
Junior subordinated debentures 253,566 253,566 253,566
Trade date securities payable 0 0 226
Accrued interest payable and other liabilities 1,387,439 1,039,490 986,092
Total liabilities 39,657,629 32,929,333 31,371,577
Shareholders' Equity:      
Common stock, no par value; $1.00 stated value; 100,000,000 shares authorized at September 30, 2020, December 31, 2019 and September 30, 2019; 58,322,775 shares issued at September 30, 2020, 57,950,803 shares issued at December 31, 2019 and 56,824,911 shares issued at September 30, 2019 58,323 57,951 56,825
Surplus 1,647,049 1,650,278 1,574,011
Treasury stock, at cost, 720,784 shares at September 30, 2020, 128,912 shares at December 31, 2019, and 126,482 shares at September 30, 2019 (44,891) (6,931) (6,799)
Retained earnings 2,001,949 1,899,630 1,830,165
Accumulated other comprehensive loss (841) (34,678) (38,877)
Total shareholders’ equity 4,074,089 3,691,250 3,540,325
Total liabilities and shareholders’ equity 43,731,718 36,620,583 34,911,902
Series D - $25 liquidation value; 5,000,000 shares issued and outstanding at September 30, 2020, December 31, 2019 and September 30, 2019      
Shareholders' Equity:      
Preferred stock, no par value; 20,000,000 shares authorized: 125,000 125,000 125,000
Series E - $25,000 liquidation value; 11,500 shares issued and outstanding at September 30, 2020 and no shares issued and outstanding at December 31, 2019 and September 30, 2019      
Shareholders' Equity:      
Preferred stock, no par value; 20,000,000 shares authorized: $ 287,500 $ 0 $ 0